Pharmaceuticals Africa

Africa Postpartum Depression Treatment Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Africa Postpartum Depression Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Drug, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $11.0 Mn Placeholder estimate
Estimate 2025 $12.7 Mn 1.7% of the global market
Projected 2034 $43.8 Mn 246.3% Adds $31.2 Mn over 9 forecast years
CAGR 2025–2034 14.8% Faster than 71% of 180 Pharmaceuticals markets here
Key players 5
  • Africa is 1.65% of the global market.
  • Among regions, the largest is North America at $333.6 Mn.
  • Fastest growing: Africa (this report) at 14.8% a year.
  • Africa ranks 6th of 6 by size among regions.

Market size projection

Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$31.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Postpartum Depression Treatment Market market size by year, Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $11.0 Mn — —
2025 (base) $12.7 Mn +$1.6 Mn —
2026 (forecast) $14.5 Mn +$1.9 Mn +14.8%
2027 (forecast) $16.7 Mn +$2.1 Mn +31.8%
2028 (forecast) $19.1 Mn +$2.5 Mn +51.3%
2029 (forecast) $22.0 Mn +$2.8 Mn +73.7%
2030 (forecast) $25.2 Mn +$3.3 Mn +99.4%
2031 (forecast) $29.0 Mn +$3.7 Mn +128.9%
2032 (forecast) $33.2 Mn +$4.3 Mn +162.8%
2033 (forecast) $38.2 Mn +$4.9 Mn +201.7%
2034 (forecast) $43.8 Mn +$5.6 Mn +246.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Africa Postpartum Depression Treatment Market Analysis at a glance
Market size, 2025$12.7 Mn placeholder estimate
Forecast, 2034$43.8 Mn placeholder estimate
Growth (CAGR), 2025–203414.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledPostpartum Depression Drugs
SegmentsTreatment, drug and end user (see all)
Key playersSage Therapeutics, Biogen Inc, Pfizer Inc., Lundbeck, Eli Lilly and Company (see all)
Regulator in AfricaAMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
Active clinical trials6 in AfricaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Africa Postpartum Depression Treatment Market Analysis Executive Summary

Postpartum depression treatment helps new mothers with depression after childbirth, using new rapid-acting medicines, antidepressants and therapy.

Key segments of the postpartum Depression Treatment market include treatment (Neuroactive Steroids, Antidepressants and Psychotherapy) and drug (Zuranolone, Brexanolone and SSRIs).

Bar chart: Africa Postpartum Depression Treatment market size, 2024–2034, placeholder estimates. $11.0 Mn in 2024, $12.7 Mn in 2025 and $43.8 Mn in 2034, 14.8% CAGR.
Africa Postpartum Depression Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Africa Postpartum Depression Treatment Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the postpartum Depression Treatment market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the postpartum Depression Treatment market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the postpartum Depression Treatment market.

Competitive Landscape for Postpartum Depression Treatment Market in Africa

The postpartum Depression Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Postpartum Depression Treatment Market in Africa

Postpartum Depression Treatment in Africa: rules, payment and research

The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together.⁠[1] In some of the countries we cover here, medicines are approved by EDA (Egypt)⁠[2], PPB (Kenya)⁠[3] and SAHPRA (South Africa)⁠[4]. How care is paid for in some of these countries: universal health insurance (Egypt)⁠[5], the SHA (Kenya)⁠[6] and planned National Health Insurance (South Africa)⁠[7]. ClinicalTrials.gov lists 6 studies on Postpartum Depression Treatment that are recruiting, active or about to start in Africa.⁠[8]

[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.

[2] Egyptian Drug Authority. Checked 14 Nov 2026.

[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.

[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.

[5] Universal Health Insurance Authority. Checked 14 Nov 2026.

[6] Social Health Authority. Checked 14 Nov 2026.

[7] National Department of Health. Checked 14 Nov 2026.

[8] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for postpartum Depression Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Postpartum Depression Treatment right now, from free public sources.

Clinical trials

6 active trials in Egypt, South Africa, Kenya, Nigeria, Ethiopia, DR Congo, Uganda, Tanzania, Niger, Mozambique, Sudan, Malawi, Zambia, Mali, Burkina Faso, Ghana and Morocco

Recruiting, about to start, or running now. Counted across the 17 countries we report on in Africa.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Postpartum Depression Treatment in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Postpartum Depression Treatment market in Africa?
Placeholder estimate: about $12.7 Mn in 2025, rising to about $43.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Postpartum Depression Treatment market in Africa growing?
Placeholder estimate: about 14.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Postpartum Depression Treatment market report cover?
The report splits the market by treatment (Neuroactive Steroids, Antidepressants, Psychotherapy, Digital Therapy), drug (Zuranolone, Brexanolone, SSRIs) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Postpartum Depression Treatment market?
Key players include Sage Therapeutics, Biogen Inc, Pfizer Inc., Lundbeck and Eli Lilly and Company.
What is driving the Postpartum Depression Treatment market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the postpartum Depression Treatment market. New products designed around women's biology and digital care are improving access.
Who regulates Postpartum Depression Treatment in Africa?
The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How many clinical trials on Postpartum Depression Treatment are running in Africa?
6 studies are recruiting, active or about to start in Africa, counted across the 17 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
How much research is published on Postpartum Depression Treatment?
PubMed lists 1,194 papers on Postpartum Depression Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Africa

See all

Related on mental health and maternal

See the topic